AAAAAA
Results:
1-11
|
Results: 11
Authors:
Narayanasami, U
Kanteti, R
Morelli, J
Klekar, A
Al-Olama, A
Keating, C
O'Connor, C
Berkman, E
Erban, JK
Sprague, KA
Miller, KB
Schenkein, DP
Citation: U. Narayanasami et al., Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation, BLOOD, 98(7), 2001, pp. 2059-2064
Authors:
Alcindor, T
Gorgun, G
Miller, KB
Roberts, TF
Sprague, K
Schenkein, DP
Foss, FM
Citation: T. Alcindor et al., Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease, BLOOD, 98(5), 2001, pp. 1622-1625
Authors:
Schenkein, DP
Koc, Y
Alcindor, T
Stadtmauer, EA
Miller, KB
Cooper, BW
Partridge, AH
Lazarus, HM
Citation: Dp. Schenkein et al., Treatment of primary resistant or relapsed multiple myeloma with high-dosechemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor, BIOL BLOOD, 6(4A), 2000, pp. 448-455
Authors:
Koc, Y
Miller, KB
Schenkein, DP
Griffith, J
Akhtar, M
DesJardin, J
Snydman, DR
Citation: Y. Koc et al., Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcome, BIOL BLOOD, 6(1), 2000, pp. 44-49
Authors:
Stiff, P
Gingrich, R
Luger, S
Wyres, MR
Brown, RA
LeMaistre, CF
Perry, J
Schenkein, DP
List, A
Mason, JR
Bensinger, W
Wheeler, C
Freter, C
Parker, WRL
Emmanouilides, C
Citation: P. Stiff et al., A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma, BONE MAR TR, 26(5), 2000, pp. 471-481
Authors:
Engels, EA
Ellis, CA
Supran, SE
Schmid, CH
Barza, M
Schenkein, DP
Koc, Y
Miller, KB
Wong, JB
Citation: Ea. Engels et al., Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk, CLIN INF D, 28(2), 1999, pp. 256-266
Authors:
Hwang, A
Schenkein, DP
Citation: A. Hwang et Dp. Schenkein, High-dose therapy with stem-cell transplantation in the malignant lymphomas - The Winter article reviewed, ONCOLOGY-NY, 13(12), 1999, pp. 1645-1646
Authors:
Kanteti, R
Miller, KB
McCann, JC
Roitman, D
Morelli, J
Hurley, C
Berkman, E
Schenkein, DP
Citation: R. Kanteti et al., Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis, BONE MAR TR, 24(5), 1999, pp. 473-481
Authors:
Koc, Y
Miller, KB
Schenkein, DP
Daoust, P
Sprague, K
Berkman, E
Citation: Y. Koc et al., Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation, CANCER, 85(3), 1999, pp. 608-615
Authors:
Koc, Y
Schenkein, DP
Citation: Y. Koc et Dp. Schenkein, Therapy of diffuse aggressive lymphomas, CANC TREAT, 99, 1999, pp. 47-73
Authors:
Scadden, DT
Schenkein, DP
Bernstein, Z
Luskey, B
Doweiko, J
Tulpule, A
Levine, AM
Citation: Dt. Scadden et al., Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma, CANCER, 83(12), 1998, pp. 2580-2587
Risultati:
1-11
|